Table 4.
Associations between ocular surface disorders and psychological, physiological states in autoimmune rheumatic patients
| Factors | OSDI | Schirmer I | TBUT | CFS | MGS | LIPCOF | DEL |
|---|---|---|---|---|---|---|---|
| SF-36 | |||||||
| Composite score | -0.42** | 0.05 | -0.01 | 0.19 | -0.10 | 0.09 | -0.15 |
| PCS score | -0.39** | 0.10 | -0.09 | 0.18 | -0.05 | 0.10 | -0.14 |
| MCS score | -0.39** | 0.01 | 0.08 | 0.17 | -0.14 | 0.07 | -0.14 |
| PF score | -0.30** | 0.11 | -0.06 | 0.17 | 0.02 | 0.09 | -0.14 |
| RP score | -0.34** | 0.08 | -0.16 | 0.19 | 0.03 | -0.04 | -0.02 |
| BP socre | -0.24** | 0.11 | 0.01 | 0.11 | -0.03 | 0.17 | -0.13 |
| GH score | -0.36** | -0.04 | -0.02 | 0.19 | -0.19 | 0.06 | -0.14 |
| VT score | -0.34** | 0.03 | 0.06 | 0.15 | -0.19 | 0.07 | -0.15 |
| SF score | -0.32** | -0.12 | 0.08 | 0.16 | -0.13 | 0.03 | -0.12 |
| RE score | -0.28** | 0.06 | 0.08 | 0.16 | -0.07 | 0.09 | -0.05 |
| MH score | -0.35** | 0.08 | 0.02 | 0.07 | -0.06 | 0.03 | -0.18 |
| HADS | |||||||
| Anxiety | 0.30** | -0.06 | 0.08 | -0.02 | -0.05 | -0.13 | 0.16 |
| Depression | 0.33** | -0.06 | 0.05 | -0.02 | -0.05 | 0.02 | 0.18 |
| PSQI | 0.44** | -0.12 | -0.14 | -0.03 | 0.14 | 0.08 | 0.20 |
| HAQ-DI | 0.18 | -0.10 | -0.02 | -0.13 | 0.06 | -0.07 | 0.09 |
OSDI Ocular Surface Disease Index, TBUT Tear film break-up time, CFS Corneal fluorescein staining, MGS Meibomian gland secretion, LIPCOF Lid-parallel conjunctival folds, DEL Dry eye level, SF-36 Short Form 36-Health Survey, PCS Physical Component Summary, MCS Mental Component Summary, PF Physical Function, RP Role Physical, BP Body Pain, GH General Health, VT Vitality, SF Social Function, RE Role Emotion, MH Mental Health, HADS Hospital Anxiety and Depression Scale, PSQI Pittsburgh Sleep Quality Index, HAQ-DI Health Assessment Questionnaire-Disability Index
P value means dry eye disease compared to systemic questionnaires among autoimmune rheumatic patients, **P < 0.01